Even though in man, cholestyramine resin produces an increase in hepatic synthesis of cholesterol, plasma cholesterol levels fall. The therapy needs to be continued to maintain cholesterol reduction. If suitable cholesterol reduction is not really attained, increasing the dosage of cholestyramine resin or including other lipid-lowering brokers in combination https://bookmarkcork.com/story15273114/how-much-you-need-to-expect-you-ll-pay-for-a-good-reduce-inflammation-balm-supplement